Skip to main content
HBIO logo
HBIO
(NASDAQ)
Harvard Bioscience, Inc.
$5.96-- (--)
Loading... - Market loading

Harvard Bioscience (HBIO) Stock Price & Financial Analysis

Harvard Bioscience Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.95 - $6.16
52-Week High$8.40
52-Week Low$0.38
Open$6.08
Volume6.12K
Average Volume (3M)25.27K
Market Cap26.66M
Shares Outstanding4.47M
Price to Sales (P/S)0.31
Price to Book (P/B)2.65
EV/EBITDA-51.86
Revenue (TTM)85.53M
Net Income (TTM)-9.78M
Free Cash Flow (TTM)1.77M
EPS (TTM)$-2.20
Profit Margin-11.44%
Operating Margin1.44%
Return on Equity (ROE)-97.39%
Debt to Equity4.39
50-Day MA$6.14
200-Day MA$4.05
52-Week Change1106.48%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Harvard Bioscience

What is the current stock price for HBIO?

As of the latest trading session, HBIO stock trades at $5.96. The 52-week range is $0.38–$8.40, with a day range of $5.95–$6.16.

What is the P/E ratio for HBIO?

The P/E ratio (Price-to-Earnings) for HBIO is shown in the Key Statistics section. This valuation metric helps compare Harvard Bioscience, Inc. to industry peers.

Does HBIO pay dividends?

Harvard Bioscience does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HBIO?

Analyst ratings and recommendations for HBIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of HBIO?

Harvard Bioscience's market capitalization is $26.7M, classifying it as a micro-cap company. Harvard Bioscience operates in the Healthcare sector within the Medical Instruments & Supplies industry.